HealthPharma & Biotech
Avid Bioservices Inc

Avid Bioservices unveils plans to raise US$20mln

The cash injection will help Avid to expand its core contract drug manufacturing business

drug manufacturing plant
Avid bulk manufactures drug substances for some of the world’s leading biopharmas

Avid Bioservices Inc (NASDAQ:CDMO) has unveiled plans to raise just over US$20mln as it looks to expand its contract drug manufacturing business.

The Tustin, California-based company - which bulk produces approved drugs for some of the world’s leading biopharmas - is selling 9mln new shares at US$2.25 each, which should bring in US$20.25mln before expenses.

Avid said it expects to have wrapped up the offering by February 20.

The stock dipped 27.6% to US$2.35 in after-hours trading, reflecting the discount at which the new shares are being issued.

Quick facts: Avid Bioservices Inc

Price: $7.08

Market: NASDAQ
Market Cap: $397.46 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Great Bear Resources releases more positive drill results...

Great Bear Resources (CVE: GBR) President and CEO Chris Taylor joined Steve Darling from Proactive Vancouver to discuss their latest assay results from the drill program on the Dixie Project in Red Lake.  Taylor discusser the results from the Hinge and Dixie Limb zones and also gave...

8 hours, 15 minutes ago

2 min read